Twenty-one MNHS projects receive NHMRC Ideas Grant funding
MNHS researchers received 21 National Health and Medical Research Council (NHMRC) Ideas Grants, worth over $25 million and announced today by the Minister for Health and Aged Care, the Honourable Mark Butler MP.
The Ideas Grant scheme's objective is to support innovative and creative research projects addressing a specific question in any health and medical research area from discovery to implementation for researchers at all career stages.
Funded projects cover diverse topics such as understanding the impact of binge drinking on kidney development, improving the diagnosis of differences in sex development and using acoustic slow waves to treat obstructive sleep apnoea.
Deputy Dean of Research Professor James Whisstock welcomed the funding and said that the grants would advance new knowledge and outcomes across multiple areas of impact. “We’re delighted to see our researchers awarded many of the highly competitive NHMRC Ideas Grants. We wish them all the best with their projects,” he said
Funded projects include:
Researcher | Funding | School/Institute | Project title |
$1,263,469.40 | School of Public Health and Preventive Medicine | Designing streets for health: developing innovative methods and tools to make cycling safe, accessible and inclusive | |
$1,102,304.40 | Monash Biomedicine Discovery Institute | Novel bioengineering solution for improving post-stroke outcomes | |
$1,914,192.00 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Exploiting epigenetic dysregulation to develop differentiation therapy in solid tumours. | |
$916,004.80 | Central Clinical School | Understanding the metabolic landscape in the human kidney in diabetes | |
$1,990,620.50 | Central Clinical School | Bringing clonal haematopoiesis (CHIP) to the clinic through screening, risk profiling and treatment | |
$1,282,017.60 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Elucidating the role of the endometrium in predicting pregnancy outcomes | |
$1,024,608.00 | School of Clinical Sciences at Monash Health | How H. pylori hijacks the nucleus: A new paradigm for cancer-causing bacteria | |
$1,350,991.30 | Monash Biomedicine Discovery Institute | COX2-driven T cell suppression in the colorectal cancer microenvironment | |
$1,232,404.20 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Molecular and Functional Dissection of Mineralocorticoid Receptor Signalling | |
$873,270.80 | Monash Biomedicine Discovery Institute | Immune responses to asymptomatic malaria: dissecting cellular signatures to overcome immunosuppression and improve vaccination strategies | |
$1,208,612.40 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Improving the diagnosis of Differences of Sex Development (DSD) | |
$1,299,786.00 | Central Clinical School | Targeting granulocyte colony-stimulating factor to prevent early-life lung disease | |
$1,444,449.60 | School of Biomedical Sciences | Non-canonical antigen sources for cross-strain protective influenza immunity | |
$751,375.80 | School of Psychological Sciences | Sound asleep: A novel approach to treating Obstructive Sleep Apnoea and associated daytime impairment with acoustic slow wave sleep enhancement | |
$1,167,939.60 | Monash Biomedicine Discovery Institute | Defining the role of MYBL2 inhibition in men with aggressive prostate cancer | |
$1,399,615.81 | Hudson Institute of Medical Research, School of Clinical Sciences at Monash Health | Transforming Treatment for Pelvic Organ Prolapse with Nanotechnology | |
$960,430.90 | School of Clinical Sciences at Monash Health | Preventing hypoperfusion-induced acute kidney injury | |
$1,311,269.20 | Central Clinical School | What determines plasma cell longevity? | |
$1,080,187.00 | Central Clinical School | Infant abusive head trauma: A new model to study chronic effects and potential biomarkers | |
$1,212,255.80 | Monash Biomedicine Discovery Institute | Understanding how binge drinking affects kidney development | |
$1,168,672.81 | Monash Biomedicine Discovery Institute | Unravelling the role of AURKA in Polycystic Kidney Disease |
For more information about the Ideas Grants, visit the NHMRC website.
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES